The Effect of the Excellence Model-Based Clinical Practice Preparation Program on Students

February 17, 2026 updated by: Öğr. Gör. Hamide COŞKUN ERÇELİK, Pamukkale University

The Effect of a Preparation Program for Clinical Practice Based on the Excellence Model on Students' Readiness, Excellence, Clinical Comfort, and Anxiety Levels: A Randomized Controlled Trial

Objective: This study was designed to develop a clinical practice preparation program based on the Pediatric Nursing Excellence Model for undergraduate nursing students and to evaluate the program's effect on students' readiness, clinical comfort and anxiety, and levels of excellence.

Method: This study is a pretest-posttest randomized controlled experimental study. The research is planned to be conducted with nursing students taking the Pediatric Health and Disease Nursing course. The study groups will consist of students who go out for clinical practice within the scope of this course. In the power analysis performed with the G*Power 3.1.9.7 program, the sample size was found to be 25 for the experimental group and 25 for the control group, for a total of 50. Research data will be collected using a questionnaire. The questionnaire consists of four sections containing the following questions: "Student Descriptive Characteristics Information Form," "Nursing Students' Readiness for Clinical Practice Scale," "Pediatric Nursing Students' Clinical Comfort and Anxiety Instrument," and "Pediatric Nursing Excellence (PHM) Model Questionnaire." In the study, students in the experimental group will receive routine orientation training and a clinical practice readiness program based on the excellence model. Students in the control group will only receive routine orientation training. Data analysis will be performed using the SPSS 20.0 software package.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: SEBAHAT ALTUNDAĞ

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • Being a nursing student,
  • Taking the Child Health and Nursing course for the first time,
  • Attending the course,
  • Not having previously taken pediatric nursing readiness training,
  • Agreeing to participate in the study voluntarily.

Exclusion criteria:

  • The student's refusal to participate in the study,
  • Withdrawal from the study before completing all stages of the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: routine orientation training and a clinical practice readiness program based on the excellence model
Other: Educational intervention
In the study, students in the experimental group will undergo a clinical practice preparation program based on the excellence model, unlike those in the control group.
No Intervention: routine orientation training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Students' Readiness Levels for Clinical Practice
Time Frame: [Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]
The assessment will be conducted using the 'Clinical Readiness Scale' developed by Avşar et al. (2024). The scale consists of 4 sub-dimensions and a total of 31 items: "Clinical Decision-Making and Application Skills," "Ensuring Safety and Effective Communication," "Basic Knowledge and Holistic Care," and "Understanding the Field of Practice." The scale is scored on a 5-point Likert scale as "strongly disagree (1)", "disagree", "somewhat agree", 'agree', and "strongly agree (5)". The scale is calculated based on the item mean score. The lowest possible score on the scale and its subscales is 1, and the highest possible score is 5. There are no reverse items on the scale. The Cronbach's alpha coefficient for the entire scale was determined to be 0.964. As the score on the scale increases, the level of readiness for clinical practice increases.
[Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Students' Clinical Comfort and Worry
Time Frame: [Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]
The 'Pediatric Nursing Students Clinical Comfort and Worry Scale' developed by Arslan et al. (2018) will be used for evaluation. The scale has two subscales: comfort level and worry level. The scale consists of a total of 11 questions, six of which assess students' comfort level during pediatric clinic practice, and five of which assess their worry level. The scale is scored on a 4-point Likert scale as "strongly agree," "agree," "disagree," and "strongly disagree." The third and fifth items in the comfort dimension of the scale are reverse-scored. The Cronbach's alpha coefficient for the comfort dimension of the scale was found to be 0.68, and the Cronbach's alpha coefficient for the worry dimension was found to be 0.89. High scores on the comfort and worry dimensions indicate higher levels of comfort and worry, respectively.
[Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]
Pediatric Nursing Excellence Level
Time Frame: [Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]
Students' levels of excellence in pediatric nursing will be assessed using the "Pediatric Nursing Excellence Model Questionnaire" prepared by the researchers. This questionnaire will be adapted from the original framework of the Pediatric Nursing Excellence (PH) model, which is based on and related to the relevant literature.
[Time Frame: one day in the first week of clinical practice] [Time Frame: one day in the third week of clinical practice] [Time Frame: one day in the last week (seventh) of clinical practice]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pamukkale University

Investigators

  • Principal Investigator: SEBAHAT ALTUNDAĞ, Pamukkale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 16, 2026

Primary Completion (Estimated)

June 16, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

February 5, 2026

First Submitted That Met QC Criteria

February 5, 2026

First Posted (Actual)

February 12, 2026

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PAMUKKALEU-COSKUNERCELİK-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Student

Clinical Trials on Educational intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe